Pfizer — Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton
Official product recall notices and clearly labeled enforcement reference records.
Reference record — not a live warning · enforcement-reference · official-source
Lack of Assurance of Sterility
- Provider
- FDA — drug enforcement reference
- Source observed
- 9/23/2026, 12:00:00 AM UTC
- Source updated
- 9/23/2026, 12:00:00 AM UTC
- Location
- Manhattan, NY, US
- hazard
- Lack of Assurance of Sterility
- notice
- Periodic enforcement reference; not a real-time safety alert or a reliable recall-lifecycle tracker.
- product
- Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01.
- distribution
- US Nationwide.
- manufacturer
- Pfizer
- recall number
- D-0853-2026
- source status
- Ongoing
- classification
- Class II
- freshness minutes
- 180
Source use policy · openFDA reference data; not a real-time public alert service
Update history (1 recent revisions)
- 10/8/2026, 1:40:27 AM UTC
Report a correction · Related news · Fire information · Clips